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The Second International RSA Meeting was held in Leiden, 
the Netherlands, in April 2011. The meeting was attended 
by 110 participants from 12 countries, including the USA, 
Canada, and not least Sweden—the country in which the clini-
cal use of RSA was initiated by Göran Selvik. The large world-
wide attendance of the meeting clearly indicates that the use 
of RSA is spreading across the world. It has not only attracted 
the attention of surgeons, researchers, and the orthopedics 
industry but also that of the regulatory bodies in Europe, the 
United States, and Australia. There is growing awareness that 
new joint replacement prostheses, cements, and surgical tech-
niques should be thoroughly evaluated before general release 
onto the market. Thus, the rather erratic introduction of new 
prostheses or new procedures should be replaced by a phased 
introduction, an approach that has been mandatory in the phar-
maceutical industry for decades (Nelissen et al. 2011).
One would expect that disasters such as with Boneloc 
cement and the Capital hip prosthesis could not happen today. 
However, in general the introduction of new prostheses is still 
done in almost the same way as it was 20 years ago. More than 
25 years ago, Malchau (1995) proposed a controlled, stepwise 
introduction of new prostheses. This message has been given 
many times, even in editorials in Acta (Bauer 1992, Kärrholm 
2003). However, recent problems with the Proxilock hip, the 
ASR hip, the Accord knee, and the St. Leger knee illustrate 
the urgent need for improved early evaluation of new pros-
theses—a process best performed in cooperation between the 
orthopedic community, industry, and regulators.
The potential of RSA as a method of early (pre-introduc-
tory) assessment of implant performance is substantial. This 
potential is currently being recognized by various regulatory 
bodies at different levels. The NICE guidelines of 2003 (UK) 
require adequate long-term clinical data for hip prostheses and 
suggest RSA as a promising technique that may be an alter-
native for long-term follow-up studies. However, additional 
proof of its predictive value regarding future loosening is not 
only advised but also demanded by regulatory bodies. In its 
new guidelines for hip prostheses, the Dutch Orthopaedic 
Society has stated that any new hip prosthesis that is being 
considered for (commercial) introduction to the Dutch market 
must go through a phased introduction (Swierstra et al. 2011). 
This phased introduction includes mandatory RSA studies 
even before larger clinical trials can be started.
Mandatory RSA studies require that the results of differ-
ent RSA studies can be compared. Thus, an international RSA 
group published the first RSA standardization paper in Acta 
Orthopaedica (Valstar et al. 2005), and a larger consortium 
with RSA experts from all over the world is now establishing 
an actual ISO standard for RSA. For ISO insiders: the draft of 
the standard is now labeled Draft International Standard and 
is currently being reviewed by all member states. The stan-
dard is expected to be finalized this year. In addition, an inter-
national RSA network is currently being established (www.
rsaresearch.org). This network is intended to be a platform 
for improvement of the quality of clinical radiostereometry 
research by sharing knowledge between research groups.
4 papers that were presented at the Second International 
RSA meeting, and selected by an international jury of RSA 
experts to be of particular interest, have been accepted for 
publication in Acta Orthopaedica. 1 of them (Wilson et al. 
2012) was published in the February issue, and the other 3 are 
published in this April issue (Aro et al. 2012, Nebergall et al. 
2012, Nieuwenhuijse et al. 2012). Furthermore, 5 other RSA 
studies are published in the current issue (Bohm et al. 2012, 
Pijls et al 2012a, b, Röhrl et al. 2012,  von Schewelov et al. 
2012).
3 of the papers in this issue of Acta present medium- to 
long-term RSA results of hip and knee prostheses. It is good 
to see that the number of medium- to long-term RSA studies 
is increasing, as this will lead to a better understanding of the 
predictive value of short-term RSA results for future implant 
failure by aseptic loosening. Nieuwenhuijse et al. (2012) pres-
ent a 10–12 year follow-up study of the Exeter stem. Pijls et 
al. (2012a) present a study on the effect of HA coating on 
the long-term fixation (up to 16 years) of the Interax total 
knee prosthesis, and Röhrl et al. (2012) present the 10-year 
results of submelt-annealed highly crosslinked polyethylene 
cemented cups.
2 papers focus on the relationship between bone mineral 
density and stem migration. The study by Aro et al. (2012) 
established the relationship between low BMD and increased 
stem migration in cementless total hip arthroplasty in a cohort 
of 57 female patients, and the study by von Schewelov et al. 
(2012) concerns the fixation of a fully HA-coated Corail stem 
for treatment of dislocated femoral neck fractures.
2 other papers deal with the effect on prosthetic migration 
of adding tobramycin to a bone cement (Bohm et al. 2012), 
and a meta-analysis confirms the predictive value of RSA for 
the high failure rate of the uncoated Interax prosthesis (Pijls 
et al. 2012b.).104  Acta Orthopaedica 2012; 83 (2): 103–104
The paper by Nebergall et al. (2012) describes a new appli-
cation of RSA, which was used to evaluate a transdermal, 
femoral implant system in above-the-knee amputee patients in 
whom the use of a conventional socket prosthesis was difficult 
if not impossible.
It is good to see that RSA is spreading across the world and 
that the number of long-term follow-up studies is increas-
ing. Such further studies may support the value of RSA for 
early prediction of prosthetic loosening; compulsory early 
RSA studies will then be part of a phased introduction of new 
implants.
The large number of research groups that are involved in 
RSA and the current developments call for another RSA meet-
ing. The next biannual International RSA Meeting is sched-
uled to take place in 2013, and will celebrate 40 years of RSA. 
We are very happy that this meeting will take place in Lund, 
Sweden, where it all started.
Edward Valstar, Bart Kaptein, and Rob Nelissen
Organisers, Second International RSA Meeting
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